• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Protein Niban (FAM129A), Truncated

ACP10701

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10701 Target NameFAM129A
Target SynonymsNIBAN1; C1orf24; FAM129A; NIBAN; GIG39; Protein Niban 1; Cell growth-inhibiting gene 39 protein; Protein FAM129AFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BZQ8
Background Information
  • Uniprot Id

    Q9BZQ8

  • Target Species

    Human

  • Target Name

    NIBAN1

  • Target Full Name

    Protein Niban 1

  • Target Function

    Regulates phosphorylation of a number of proteins involved in translation regulation including EIF2A, EIF4EBP1 and RPS6KB1. May be involved in the endoplasmic reticulum stress response.

  • Target Subcellular Location

    Cytoplasm. Membrane; Lipid-anchor.

  • Target Protein Families

    Niban family

  • Target Tissue Specificity

    Expressed in various types of thyroid tumor such as papillary thyroid carcinomas and oxyphilic thyroid tumors but not in normal thyroid tissue (at protein level). Strongly expressed in heart, skeletal muscle, pancreas, white blood cells and prostate with

  • Target Synonyms

    NIBAN1; C1orf24; FAM129A; NIBAN; GIG39; Protein Niban 1; Cell growth-inhibiting gene 39 protein; Protein FAM129A

Inquire Recombinant Human Protein Niban (FAM129A), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification